Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateGregory Hook(American Life Science Pharmaceuticals (United States)), Vivian Hook(Harvard University)Frontiers in NeurologySeptember 2, 201510.3389/fneur.2015.00178Cited by 102SaveCiteExport RISWatch citationsRelated PapersThe NASA Twins Study: A multidimensional analysis of a year-long human spaceflight|Science|2019|1.1k